Aquark partnered with the Royal Navy for a second time to demonstrate that the AQlock cold atom clock can deliver stable, functional outputs under real-world conditions.
During it's first trial at sea, the AQlock, functioned continuously the Solent area over three days. The trial was facilitated and endorsed by the Disruptive Capabilities and Technologies Office (DCTO) of the Royal Navy.
Aquark Technologies raises €5m in seed financing led by NATO Innovation Fund with significant investments from EIFO, UKI2S (managed by Future Planet Capital), and MBDA.